Skip to content

Clinical trials

Observational Hemorrhage trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Observational Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20151
20172
20181
20192
20202
20225
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status5
Recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
Anthos Therapeutics, Inc.1
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari1
Casa Sollievo della Sofferenza IRCCS1
Centro Cardiologico Monzino1
Fondazione Angelo Bianchi Bonomi1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
G. d'Annunzio University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage22
Thrombosis3
Anemia2
Hypovolemia2
Myocardial Infarction2
Anastomotic Leak1
Atrial Fibrillation1
Blood Coagulation Disorders1
Blood Platelet Disorders1
Cardiovascular Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.